Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
about
Mapping and quantification of the major oligosaccharide components of heparinContaminated heparin-affected patient plasmas are associated with activated contact systems.A new approach for heparin standardization: combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis.Structural characterization of pharmaceutical heparins prepared from different animal tissues.Role of endothelial cell surface heparin-like polysaccharides.Glycosaminoglycans and the regulation of blood coagulation.Chiral capillary electrophoresis with noncyclic oligo- and polysaccharide chiral selectors.Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane.Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen.Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificitiesEffect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor XaActivation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.Lipoprotein lipase: cellular origin and functional distribution.Chemical reduction of carboxyl groups in heparin abolishes its vasodilatory activity
P2860
Q24528185-F4E1F827-101D-4420-94AC-109D3CCC6B41Q33390123-9ED6108B-7FFB-4288-8901-B839ED17D2F8Q33803900-5AE6580E-9A8B-43D7-81CC-91AAB2D5954FQ37400253-F138E813-5B1B-4802-9D8F-23893F7A25B7Q38647598-95A4FD24-C2CD-4C06-B855-4629AD00E201Q40851193-88854CE3-65EA-4A59-ABEF-A81644DEC411Q41696590-0493179C-6D88-456A-960D-5EDA3B87925BQ41883867-EEFB1B57-0578-4219-B4B8-10113452C0FFQ42126811-2D18F6DA-828C-4F05-9BE8-09978C7231D9Q42276329-48F0D7B0-668B-4954-927E-7D16BCF6C694Q42802874-9E63B1EC-698B-47EA-ADF5-9E2457E06881Q42836585-FD06D0F7-C751-476B-A3DA-9C40DF113317Q42857980-2811A95B-2B48-480C-9FD7-FDB37C9F142CQ46819418-1AF4FAD8-24D8-4555-A696-D8FB68FE3EFBQ57975635-81058701-17D2-4C37-8E09-178B0320DC54
P2860
Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Biological implications of the ...... eparins and heparan sulphates.
@en
Biological implications of the ...... eparins and heparan sulphates.
@nl
type
label
Biological implications of the ...... eparins and heparan sulphates.
@en
Biological implications of the ...... eparins and heparan sulphates.
@nl
prefLabel
Biological implications of the ...... eparins and heparan sulphates.
@en
Biological implications of the ...... eparins and heparan sulphates.
@nl
P2093
P2860
P356
P1433
P1476
Biological implications of the ...... eparins and heparan sulphates.
@en
P2093
P2860
P304
P356
10.1042/BJ2370573
P407
P577
1986-07-01T00:00:00Z